Effects of phospholipase A2, free fatty acids and 2-lysolecithin on the crystallization of cholesterol in gallbladder bile.
BACKGROUND
Phospholipase A2 (PLA2) and its enzymatic products free fatty acids (FFAs) and 2-lysolecithin are physiological constituents of bile. Their role in the crystallization of cholesterol in gallbladder bile of patients with cholesterol gallstones is still controversial.


METHODS
To clarify this issue we evaluated the activity of PLA2 and the concentration and pattern of FFAs in the gallbladder bile of cholesterol stone patients. We furthermore added PLA2, FFAs and 2-lysolecithin to isotropic gallbladder bile, determined the crystal observation time (COT) and counted the cholesterol crystals in a crystal growth assay for up to 21 days.


RESULTS
A PLA2 activity of 1.8 +/- 1.2 U L(-1) and total FFA concentrations of 1.32 +/- 0.71 mmol L(-1) were determined. After incubation of bile for 24 h at 37 degrees C total FFAs increased to 2.72 +/- 1.29 mmol L(-1) (P<0.005). Biliary saturated and unsaturated FFAs were found in equal proportions before and after incubation, pointing to an additional presence of lipases other than PLA2. A COTof 1 day was observed in all gallbladder biles and increased to 1.7 +/- 0.5 days after addition of 5 U L(-1) of PLA2 (P<0.01). An even higher COT of 2.5 +/- 0.8 days was seen after addition of 5 mmol L(-1) of a 'biliary' mixture of FFAs (P<0.005) but the COT remained unchanged after addition of 5 mmol L(-1) of 2-lysolecithin. However, in the crystal growth assay in gallbladder bile addition of 5 U L(-1) of PLA2, of 5 mmol L(-1) of 'biliary' FFAs and of 5 mmol L(-1) of 2-lysolecithin decreased significantly the number of cholesterol crystals formed during follow-up.


CONCLUSIONS
An elevated activity of PLA2 in gallbladder bile may counteract the formation of cholesterol crystals through increased formation of FFAs and 2-lysolecithin. However, regarding the comparatively low activity of PLA2 in gallbladder bile PLA2 seems to be of only minor pathophysiological importance in the formation of cholesterol gallstones.
Schöne
A
A
Department of Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany.
Jüngst
D
D
Meyer
G
G
Hernandez-Richter
T
T
Fischer
S
S
D000328:Adult; D000368:Aged; D016718:Arachidonic Acid / Q000737:chemistry / Q000378:metabolism; D001646:Bile / Q000201:enzymology / Q000378:metabolism; D002247:Carbon Isotopes / Q000378:metabolism; D002769:Cholelithiasis / Q000737:chemistry / Q000378:metabolism*; D002784:Cholesterol / Q000737:chemistry* / Q000378:metabolism; D003460:Crystallization; D005230:Fatty Acids, Nonesterified / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D005704:Gallbladder / Q000378:metabolism*; D006801:Humans; D008244:Lysophosphatidylcholines / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010741:Phospholipases A / Q000737:chemistry / Q000378:metabolism*; D054467:Phospholipases A2; D013997:Time Factors
D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D008244:Lysophosphatidylcholines; D016718:Arachidonic Acid; D002784:Cholesterol; D010741:Phospholipases A; D054467:Phospholipases A2